1. Home
  2. RYTM vs ZK Comparison

RYTM vs ZK Comparison

Compare RYTM & ZK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • ZK
  • Stock Information
  • Founded
  • RYTM 2008
  • ZK 2017
  • Country
  • RYTM United States
  • ZK China
  • Employees
  • RYTM N/A
  • ZK N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • ZK
  • Sector
  • RYTM Health Care
  • ZK
  • Exchange
  • RYTM Nasdaq
  • ZK NYSE
  • Market Cap
  • RYTM 4.3B
  • ZK 5.0B
  • IPO Year
  • RYTM 2017
  • ZK 2024
  • Fundamental
  • Price
  • RYTM $61.99
  • ZK $25.99
  • Analyst Decision
  • RYTM Strong Buy
  • ZK Strong Buy
  • Analyst Count
  • RYTM 12
  • ZK 3
  • Target Price
  • RYTM $76.75
  • ZK $32.13
  • AVG Volume (30 Days)
  • RYTM 525.0K
  • ZK 448.2K
  • Earning Date
  • RYTM 08-05-2025
  • ZK 05-15-2025
  • Dividend Yield
  • RYTM N/A
  • ZK N/A
  • EPS Growth
  • RYTM N/A
  • ZK N/A
  • EPS
  • RYTM N/A
  • ZK N/A
  • Revenue
  • RYTM $136,863,000.00
  • ZK $10,494,129,543.00
  • Revenue This Year
  • RYTM $37.56
  • ZK N/A
  • Revenue Next Year
  • RYTM $74.99
  • ZK $28.16
  • P/E Ratio
  • RYTM N/A
  • ZK N/A
  • Revenue Growth
  • RYTM 48.88
  • ZK 17.46
  • 52 Week Low
  • RYTM $39.46
  • ZK $13.00
  • 52 Week High
  • RYTM $69.89
  • ZK $33.32
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 47.67
  • ZK N/A
  • Support Level
  • RYTM $60.70
  • ZK N/A
  • Resistance Level
  • RYTM $62.65
  • ZK N/A
  • Average True Range (ATR)
  • RYTM 2.39
  • ZK 0.00
  • MACD
  • RYTM -0.52
  • ZK 0.00
  • Stochastic Oscillator
  • RYTM 14.04
  • ZK 0.00

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

About ZK ZEEKR INTELLIGENT TECHNOLOGY HLDG L SPON ADS EA REP 10 ORD SHS

ZEEKR Intelligent Technology Holding Ltd is a fast-growing BEV technology company. By developing and offering next-generation premium BEVs and technology-driven solutions, It aspires to lead the automobile industry's electrification, intelligentization and innovation. Since its inception, It has focused on innovation in BEV architecture, hardware, software, and application of new technologies. It is principally engaged in the commercialization and sales of electric vehicles and batteries, and the provision of automotive-related research and development services.

Share on Social Networks: